GlassScriptPhysician profile
Ann S Mccray
NPI 1619036639
$9,323.94
in general payments reported to CMS, 2019-2025
38 companies · $2,772 in 2025
The $2,772 reported for 2025 was more than what 98% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $438 · 2020: $280 · 2021: $1,524 · 2022: $1,221 · 2023: $1,181 · 2024: $1,908 · 2025: $2,772.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,861.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,861.23 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $1,894.26 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Pfizer INC. | $1,093.15 | 2019-2025 | |
| Abbvie INC. | $956.77 | 2019-2025 | |
| Astrazeneca Pharmaceuticals LP | $794.05 | 2020-2025 | Airsupra, Farxiga, Breztri |
| Madrigal Pharmaceuticals | $662.79 | 2024-2025 | Rezdiffra |
| Glaxosmithkline, LLC. | $509.97 | 2021-2025 | Shingrix, Trelegy Ellipta, Arexvy |
| Lilly USA, LLC | $492.82 | 2019-2025 | Mounjaro, Zepbound, Trulicity |
| Takeda Pharmaceuticals U.S.A., INC. | $368.22 | 2020-2024 | Trintellix, Glassia |
| Exact Sciences Corporation | $324.43 | 2023-2025 | Cologuard Collection Kit |
| Amgen INC. | $311.03 | 2021-2025 | Repatha, Otezla, Otezla |
| Bayer Healthcare Pharmaceuticals INC. | $191.96 | 2023-2024 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $185.33 | 2022-2025 | Caplyta |
| Biohaven Pharmaceuticals, INC. | $175.72 | 2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $170.70 | 2020-2025 | Jardiance, Synjardy |
| Otsuka America Pharmaceutical, INC. | $151.77 | 2024-2025 | Rexulti |
Show all 38 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ann Mccray listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.